Skip to main content

D. E. Shaw & Co., Inc.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$32,174,439
-$3,012,266 QoQ
Shares Held
622,450
-12.1% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. SUPN ranks #8 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 SUPN
Supernus Pharmaceuticals, Inc.
This page
622,450 $32,174,439

All Filings in SUPN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $32,174,439 622,450
2025-12-31 $35,186,705 707,982
2025-09-30 $46,815,274 979,604
2025-06-30 $18,868,533 598,621
2025-03-31 $15,323,102 467,881
2024-12-31 $19,730,993 545,658
2024-09-30 $12,746,009 408,788
2024-06-30 $7,778,819 290,797
2024-03-31 $4,446,784 130,366
2023-12-31 $3,737,687 129,153
2023-09-30 $689,884 25,023
2023-06-30 $736,470 24,500
2023-03-31 $1,060,669 29,276
2022-12-31 $1,047,021 29,353
2022-09-30 $920,720 27,200
2022-06-30 $465,612 16,100
2022-03-31 $250,156 7,740
2021-06-30 $305,529 9,923
2021-03-31 $386,521 14,764
2020-12-31 $538,600 21,407
2020-09-30 $2,886,840 138,524
2020-06-30 $5,504,655 231,775
2020-03-31 $4,110,318 228,478